Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

the Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Spastic Stroke Patient. The Patients Were Diagnosed With the Lateral Scapular Slide Test, Fugl-Meyer Upper Extremity (FMUE) Scale Scores & Scapular Balance Angle Test (SBA).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04004949
Recruitment Status : Completed
First Posted : July 2, 2019
Last Update Posted : July 2, 2019
Sponsor:
Information provided by (Responsible Party):
Lama Saad El-Din Mahmoud, October 6 University

Brief Summary:
to investigate the effect of Scapular dyskinesia on the scapular balance angle & upper extremity Sensorimotor Function in spastic stroke patient.

Condition or disease Intervention/treatment
Post Stroke Scapular Dyskinesia Other: scapular dyskinesia measurement

Detailed Description:

Background: Post stroke Scapular dyskinesia leads to scapulohumeral pain & dysfunction were associated with decreased motor function, somatosensory function, limited range of motion, and spasticity.

Objective: to investigate the effect of Scapular dyskinesia on the scapular balance angle & upper extremity Sensorimotor Function in spastic stroke patient.

Methods: sixty patients from both sexes were participated in this study. All the patients were diagnosed as spastic stroke patients. The patients were divided into two equal groups; group A (30 patients): with high scapular dyskinesia scores, group B (30 patients): with low or no scapular dyskinesia scores. The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 60 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 1 Day
Official Title: The Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Stroke Patients With Spasticity
Actual Study Start Date : March 1, 2019
Actual Primary Completion Date : June 5, 2019
Actual Study Completion Date : June 5, 2019

Group/Cohort Intervention/treatment
study group (high scapular dyskinesia )
group A (30 patients): with high scapular dyskinesia scores
Other: scapular dyskinesia measurement
The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).
Other Name: group A (30 patients): with high scapular dyskinesia scores

control group (low or no scapular dyskinesia )
group B (30 patients): with low or no scapular dyskinesia scores. (30 patients): with low or no scapular dyskinesia scores.
Other: scapular dyskinesia measurement
The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).
Other Name: group A (30 patients): with high scapular dyskinesia scores




Primary Outcome Measures :
  1. the Lateral scapular slide test [ Time Frame: 1 day ]

    for the measurement of scapular dyskinesia, the Lateral scapular slide test using Palpation meter (PALM) device,

    marked inferior angles of scapula and the other arm was moved to reach the marked corresponding spinous process Both sides' readings were recorded and the differences between them were calculated

    Bilateral difference of 1.5 cm considered the threshold for deciding whether scapular asymmetry is abnormal A distance 1.5 cm greater than the contralateral side in any position suggests scapulothoracic weakness with secondary scapulothoracic protraction


  2. Fugl-Meyer Assessment (FMA) scale [ Time Frame: 1 day ]

    Fugl-Meyer upper extremity (FMUE) Scale scores is an index to assess the sensorimotor impairment in individuals who had stroke.

    The motor section score ranges from 0 to 66, and the score related to exteroceptive and proprioceptive sensitivity ranges from 0 to 12. The lowest and highest scores correspond to worse and better function, respectively FMUE Scale scores < 31 corresponded with 'no to poor' upper extremity capacity, while 32 to 47 represented 'limited capacity', 48 to 52 represented 'notable capacity' and 53 to 66 represented 'full' upper extremity capacity


  3. scapular balance angle (SBA): [ Time Frame: 1 day ]

    for Measurement of scapular balance angle

    The inferior angle of the scapula was marked bilaterally and a line was drawn connecting these marks. Another vertical line between C7 and T10 spinous processes was drawn. The angles formed by the line joining both inferior angles of the scapula with the vertical line running through the spine were measured (The difference between these two angles corresponded to the scapular balance angle The values for the SBA in healthy population were 2.505±2.340° while the abnormality criteria were with an angle greater than 7.185°




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   35 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Sixty stroke patients were randomly selected from Kasr El-Aini Neurological Department, outpatient clinic of Faculty of Physical Therapy, Cairo University, October 6 university hospital.
Criteria

Inclusion Criteria:

  • patient diagnosed as stroke patient
  • stroke onset at least 5 months prior to study enrollment and
  • decreased sensorimotor function in the affected arm, but ability to use the arm to some extent in daily activities with functional to subfunctional manual muscle test
  • age ranged from 35:50
  • both sexes

Exclusion Criteria:

  • difficulty to communicate or to understand test instructions
  • other conditions that caused pain (for example fibromyalgia and arthritis)
  • severe depression or other psychiatric symptoms
  • patient with other upper limb musculoskeletal problems

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04004949


Locations
Layout table for location information
Egypt
October 6 University
Giza, El-Sheikh Zayed City Giza 1133 Egypt, Egypt
Sponsors and Collaborators
Lama Saad El-Din Mahmoud
Layout table for additonal information
Responsible Party: Lama Saad El-Din Mahmoud, lecturer of neurology & neurosurgery for physical therapy, October 6 University
ClinicalTrials.gov Identifier: NCT04004949    
Other Study ID Numbers: 12341234
First Posted: July 2, 2019    Key Record Dates
Last Update Posted: July 2, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: publication research study

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Dyskinesias
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Movement Disorders
Neurologic Manifestations
Signs and Symptoms